Jessica Chen has over 10 years' experience in investment, business development and strategy planning background with multi-national companies top in healthcare industry. She has invested 200 million RMB in growth/clinical stage biotech companies. Miss Chen joined BOCG in 2017 and she has deeply involved in the investment of Boan Biotech, Ribo Life Sciences, Koka Lifesciences and Hightide Therapeutics. Prior to joining BOCG, Miss Chen worked as investment and strategy manager in Sanofi, with experienced business development (in/out-licensing, alliance partnership), merger and acquisition projects, involved projects like Genzyme, JHL, Sunstone Pharma, etc.
‍
She has a Master degree of Business and Economics from Loughborough University and Bachelor degree of Materials Engineering from Beijing University of Chemical Technology.